DEPLOYDatabase

Partnership

Rex Bionics x US Army

Rex Bionics signed a collaboration agreement with the US Army to investigate the use of the REX exoskeleton in an acute care setting for early rehabilitation of amputees. The partnership supports Rex Bionics' US market expansion strategy.

development · Announced · just announced


Machine-readable surfaces

80ce687b-5905-44a2-be49-6ae03b8d696d
Type
development
Status
Announcedjust announced
Announced
2016-03-10
10.5 years ago
Active for
10.5 years

Who’s involved

Rex Bionicstechnology provider

Rex Bionics develops the [REX](/models/rex-bionics-rex) robotic exoskeleton, a hands-free, self-supporting mobility device that enables wheelchair users with spinal cord injury and other neurological conditions to stand, walk, and exercise. Founded in Auckland in 2003, the company pioneered Robot-Assisted Physiotherapy (RAP) and ran the RAPPER II clinical trial across leading neuro-rehabilitation clinics in the UK and Australia. Rex Bionics was admitted to trading on the London Stock Exchange's AIM in 2014 under the ticker RXB.

HQAuckland, New Zealandrexbionics.com3 partnerships

Off-registry parties

  • US Army · co developer

Related partnerships

Other deals between the same parties

Other partnerships of Rex Bionics

Recent partnerships of the same kind

Sources (1)

  1. https://biosciencemanagers.com/rxb-trading-update/

Deploy Watch

Track this partnership.

We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.